Filter
432
Text search:
HIV
coinfection
Featured
Recommendations
46
New Publications
121
Language
Document type
No document type
307
Studies & Reports
44
Guidelines
43
Situation Updates
11
Fact sheets
7
Strategic & Response Plan
6
Manuals
5
Training Material
5
Infographics
2
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
18
Eastern Europe
17
Nepal
16
India
15
Latin America and the Carribbean
14
Asia
10
Rwanda
8
Namibia
8
South–East Asia Region
8
Global
8
Kenya
7
Tanzania
7
Ukraine
7
Myanmar / Burma
7
Congo, Democratic Republic of
6
Malawi
6
Russia
6
Nigeria
5
Ethiopia
5
Philippines
5
Zambia
5
Cambodia
5
South Africa
5
Sierra Leone
4
Ghana
4
Bangladesh
4
Argentina
3
Africa
3
Liberia
2
Senegal
2
Uganda
2
Zimbabwe
2
Mozambique
2
Benin
2
Peru
2
Brazil
2
Madagascar
2
Eastern Europe and Central Asia
2
Albania
2
Armenia
2
Tajikistan
2
Georgia
2
Haiti
1
Pakistan
1
Germany
1
Thailand
1
Indonesia
1
Central African Republic
1
Eswatini/ Swaziland
1
Colombia
1
Ecuador
1
East and Southern Africa
1
Paraguay
1
Laos
1
Estonia
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
North America
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
154
Clinical Guidelines
60
Public Health
6
Pharmacy & Technologies
5
Women & Child Health
4
Key Resources
4
Capacity Building
3
Toolboxes
TB
129
HIV
124
NTDs
17
Refugee
8
COVID-19
7
AMR
3
Caregiver
3
Ebola
2
Rapid Response
2
Mental Health
2
Global Health Education
2
Pharmacy
2
Polio
1
Conflict
1
Zika
1
Planetary Health
1
Health Financing Toolbox
1
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start
...
Evaluation report
September 2014
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care.
...
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421